Skip to main content

Nelsen Robert's Form 4 filing

Prime Medicine, Inc. (PRME) · filed Oct 26, 2022

Accession no.
0001628280-22-027124
Filed
Oct 26, 2022
Trade date
Oct 24, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 5 non-derivative transactions and 5 derivative transactions. Open-market purchases total $13.6M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Nelsen RobertCIK 0001219042Director, 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 24, 2022Common StockCConversionAcquired+5,728,297––5,728,297Indirect
Oct 24, 2022Common StockCConversionAcquired+5,728,297––5,728,297Indirect
Oct 24, 2022Common StockPPurchaseAcquired+400,000$17.00+$6,800,0006,128,297Indirect
Oct 24, 2022Common StockPPurchaseAcquired+400,000$17.00+$6,800,0006,128,297Indirect
Oct 24, 2022Common StockCConversionAcquired+16,080––16,080Indirect

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Oct 24, 2022Common StockCConversionDisposed−5,361,122$0.00$00Indirect
Oct 24, 2022Common StockCConversionDisposed−5,361,122$0.00$00Indirect
Oct 24, 2022Common StockCConversionDisposed−367,175$0.00$00Indirect
Oct 24, 2022Common StockCConversionDisposed−367,175$0.00$00Indirect
Oct 24, 2022Common StockCConversionDisposed−16,080$0.00$00Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)